Serveur d'exploration sur la COVID en France - Exploration (Accueil)

Index « Titre (en) » - entrée « protocol »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
prothrombotic < protocol < protocols  Facettes :

List of bibliographic references indexed by protocol

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000264 (2020) Hillard S. Kaplan [États-Unis] ; Benjamin C. Trumble [États-Unis] ; Jonathan Stieglitz [France] ; Roberta Mendez Mamany ; Maguin Gutierrez Cayuba ; Leonardina Maito Moye ; Sarah Alami [États-Unis] ; Thomas Kraft [France] ; Raul Quispe Gutierrez ; Juan Copajira Adrian ; Randall C. Thompson [États-Unis] ; Gregory S. Thomas [États-Unis] ; David E. Michalik [États-Unis] ; Daniel Eid Rodriguez ; Michael D. Gurven [États-Unis]Voluntary collective isolation as a best response to COVID-19 for indigenous populations? A case study and protocol from the Bolivian Amazon.
000476 (2020) Daniele De Luca [France] ; Lucilla Rava [Italie] ; Simon Nadel [Royaume-Uni] ; Pierre Tissieres [France] ; Orsola Gawronski [Italie] ; Elisabeth Perkins [Australie] ; Giovanna Chidini [Italie] ; David G. Tingay [Australie]The EPICENTRE (ESPNIC Covid pEdiatric Neonatal Registry) initiative: background and protocol for the international SARS-CoV-2 infections registry.
000493 (2020) Justin T. Denholm [Australie] ; Joshua Davis [Australie] ; David Paterson [Australie] ; Jason Roberts [Australie, France] ; Susan Morpeth [Nouvelle-Zélande] ; Thomas Snelling [Australie] ; Dominica Zentner [Australie] ; Megan Rees [Australie] ; Matthew O'Sullivan [Australie] ; David Price [Australie] ; Asha Bowen [Australie] ; Steven Y C. Tong [Australie]The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial.
000802 (2020) Marie-Astrid Piquet [France] ; Benoit Dupont [France]Re. Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol.
000814 (2020) Eric Azabou [France] ; Guillaume Bao [France] ; Nicholas Heming [France] ; Rania Bounab [France] ; Pierre Moine [France] ; Sylvain Chevallier [France] ; Sylvie Chevret [France] ; Matthieu Resche-Rigon [France] ; Shidaps Siami [France] ; Tarek Sharshar [France] ; Frederic Lofaso [France] ; Djillali Annane [France]Randomized Controlled Study Evaluating Efficiency of Low Intensity Transcranial Direct Current Stimulation (tDCS) for Dyspnea Relief in Mechanically Ventilated COVID-19 Patients in ICU: The tDCS-DYSP-COVID Protocol.
000848 (2020) Florence Ader [France]Protocol for the DisCoVeRy trial: multicentre, adaptive, randomised trial of the safety and efficacy of treatments for COVID-19 in hospitalised adults.
000849 (2020) Katharine H D. Crawford [États-Unis] ; Rachel Eguia [États-Unis] ; Adam S. Dingens [États-Unis] ; Andrea N. Loes [États-Unis] ; Keara D. Malone [États-Unis] ; Caitlin R. Wolf [États-Unis] ; Helen Y. Chu [États-Unis] ; M Alejandra Tortorici [États-Unis, France] ; David Veesler [États-Unis] ; Michael Murphy [États-Unis] ; Deleah Pettie [États-Unis] ; Neil P. King [États-Unis] ; Alejandro B. Balazs [États-Unis] ; Jesse D. Bloom [États-Unis]Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays.
001059 (2020) Mary Daval [France] ; Alain Corré [France] ; Clement Palpacuer [France] ; Juliette Housset [France] ; Guillaume Poillon [France] ; Michael Eliezer [France] ; Benjamin Verillaud [France] ; Dorsaf Slama [France] ; Denis Ayache [France] ; Philippe Herman [France] ; Clement Jourdaine [France] ; Camille Hervé [France] ; Wissame El Bakkouri [France] ; Dominique Salmon [France] ; Charlotte Hautefort [France]Efficacy of local budesonide therapy in the management of persistent hyposmia in COVID-19 patients without signs of severity: A structured summary of a study protocol for a randomised controlled trial.
001064 (2020) J P Desilles [France, États-Unis] ; C. Gregoire [France] ; C. Le Cossec [France] ; J. Lambert [France] ; O. Mophawe [France] ; M R Losser [France] ; F. Lambiotte [France] ; S. Le Tacon [France] ; M. Cantier [France] ; N. Engrand [France] ; P. Trouiller [France] ; J. Pottecher [France]Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial.
001213 (2020) Jonathan A C. Sterne [Royaume-Uni] ; Janet Diaz [Suisse] ; Jesús Villar [Espagne] ; Srinivas Murthy [Canada] ; Arthur S. Slutsky [Canada] ; Anders Perner [Danemark] ; Peter Jüni [Canada] ; Derek C. Angus [États-Unis] ; Djillali Annane [France] ; Luciano Cesar Pontes Azevedo [Brésil] ; Bin Du [République populaire de Chine] ; Pierre-Francois Dequin [France] ; Anthony C. Gordon [Royaume-Uni] ; Cameron Green [Australie] ; Julian P T. Higgins [Royaume-Uni] ; Peter Horby [Royaume-Uni] ; Martin J. Landray [Royaume-Uni] ; Giuseppe Lapadula [Italie] ; Amelie Le Gouge [France] ; Marie Leclerc [France] ; Jelena Savovi [Royaume-Uni] ; Bruno Tomazini [Brésil] ; Balasubramanian Venkatesh [Australie] ; Steve Webb [Australie] ; John C. Marshall [Canada]Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials.
001805 (2020) Alain Vandormael [Allemagne, Afrique du Sud] ; Maya Adam [États-Unis] ; Merlin Greuel [Allemagne] ; Till B Rnighausen [Allemagne, États-Unis, Afrique du Sud]A short, animated video to improve good COVID-19 hygiene practices: a structured summary of a study protocol for a randomized controlled trial.
001854 (2020) Keisha Smith [États-Unis] ; Amy Pace [États-Unis] ; Stephan Ortiz [États-Unis] ; Shamsah Kazani [États-Unis] ; Scott Rottinghaus [États-Unis]A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "protocol" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "protocol" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    protocol
}}

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021